宏信证券：每日信息速递-20250109

Economic News Summary - The "Guidelines for the Construction of a National Unified Market (Trial)" have been released, aiming to prevent illegal interference in economic disputes and protect the rights of business entities [3][4] - In 2024, the number of valid domestic invention patents reached 4.756 million, with a 15.7% year-on-year increase in valid patents for strategic emerging industries [8][10] - Major policies supporting technological innovation and manufacturing development resulted in tax reductions and refunds of approximately 2.3 trillion yuan in the first 11 months of 2024 [11][12] - As of December 2024, China's foreign exchange reserves stood at 320.24 billion USD, a decrease of 6.35 billion USD from the previous month [12] Industry News Summary - In 2024, 117,000 judicial auction residential properties were sold nationwide, with over 51% being second auction sales, reflecting a 1.9% decrease in total transaction value year-on-year [13][14] - The number of newly issued closed-end equity financial products significantly increased in December 2024, with 2,733 new products launched, indicating a growing market activity [15][16] - The futures market in 2024 saw a year-on-year increase of 8.93% in total transaction value, with a total of 6.192 trillion yuan [16][17] Company-Specific Announcements - Goldfield Group reported a cumulative signed amount of 68.51 billion yuan in 2024, a year-on-year decrease of 55.39% [20] - Hopu Co. plans to merge its wholly-owned subsidiary, Shanghai Qianxu, into its planning subsidiary to optimize its organizational structure [24] - Baicheng Pharmaceutical's HQ2303 received clinical trial approval for hypertension treatment, marking a significant development in its product pipeline [25] - TaoTao Automotive plans to invest up to 600 million yuan in a golf cart production project [26] - Dongfang Electric's subsidiary transferred a 51% stake in "Mulei Dongxin" for 929 million yuan [27] - Zhonghe Technology won a bid for a 300 million yuan project for the Shenyang Metro Line 10 signal system integration [28] - Newnow's subsidiary received approval for clinical trials of SYS6045, a drug for treating late-stage solid tumors [29] - New World received approval for the listing application of etomidate raw materials, a non-barbiturate intravenous anesthetic [30] - Rongfa Nuclear Power won a bid for a 106 million yuan project in Shandong Haiyang Nuclear Power [31] - Samsung Medical's subsidiary signed a 1.23 billion IDR contract with the Indonesian Electricity Bureau for power supply [32]